Question 3

10/16/2019

Safe and comprehensive treatment of opioid use disorder with buprenorphine in the outpatient setting in close collaboration with nurses is possible because many aspects of care can be based on established protocols.   True true Evidence supports collaboration with nurses and other collaborative t

/Templates/Article.aspx?id=4294991904

Question 3

10/16/2019

Safe and comprehensive treatment of opioid use disorder with buprenorphine in the outpatient setting in close collaboration with nurses is possible because many aspects of care can be based on established protocols.   True true Evidence supports collaboration with nurses and other collaborative t

/Templates/Article.aspx?id=4294991939

Question 2

10/16/2019

Mr. Scott is a 47 yo gentleman you are treating for opioid use disorder with buprenorphine. Recently he has had a number of difficult life circumstances including a divorce, a demotion at work, and worsening of his chronic back pain. His last few toxicologies have shown some fentanyl and oxycodone, which are not

/Templates/Article.aspx?id=4294991903

Question 3

10/16/2019

Safe and comprehensive treatment of opioid use disorder with buprenorphine in the outpatient setting in close collaboration with nurses is possible because many aspects of care can be based on established protocols.   True true Evidence supports collaboration with nurses and other collaborative t

/Templates/Article.aspx?id=4294991802

Question 2

10/16/2019

Mr. Scott is a 47 yo gentleman you are treating for opioid use disorder with buprenorphine. Recently he has had a number of difficult life circumstances including a divorce, a demotion at work, and worsening of his chronic back pain. His last few toxicologies have shown some fentanyl and oxycodone, which are not

/Templates/Article.aspx?id=4294991801

Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/Article.aspx?id=4294992249

Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/Article.aspx?id=4294991902

Question 3

10/16/2019

Safe and comprehensive treatment of opioid use disorder with buprenorphine in the outpatient setting in close collaboration with nurses is possible because many aspects of care can be based on established protocols.   True true Evidence supports collaboration with nurses and other collaborative t

/Templates/Article.aspx?id=4294992251

Question 2

10/16/2019

Mr. Scott is a 47 yo gentleman you are treating for opioid use disorder with buprenorphine. Recently he has had a number of difficult life circumstances including a divorce, a demotion at work, and worsening of his chronic back pain. His last few toxicologies have shown some fentanyl and oxycodone, which are not

/Templates/Article.aspx?id=4294992250

Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/Article.aspx?id=4294991920